These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1184 related items for PubMed ID: 10862051

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.
    Leroy K, Dumas V, Martin-Garcia N, Falzone MC, Voisin MC, Wechsler J, Revuz J, Créange A, Levy E, Lantieri L, Zeller J, Wolkenstein P.
    Arch Dermatol; 2001 Jul; 137(7):908-13. PubMed ID: 11453810
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [From gene to disease; neurofibromatosis type 1].
    de Goede-Bolder A, Cnossen MH, Dooijes D, van den Ouweland AM, Niermeijer MF.
    Ned Tijdschr Geneeskd; 2001 Sep 08; 145(36):1736-8. PubMed ID: 11572174
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
    Friedrich RE, Keiner D, Hagel C.
    Anticancer Res; 2007 Sep 08; 27(4A):2085-90. PubMed ID: 17649826
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors.
    Holtkamp N, Mautner VF, Friedrich RE, Harder A, Hartmann C, Theallier-Janko A, Hoffmann KT, von Deimling A.
    Acta Neuropathol; 2004 Feb 08; 107(2):159-68. PubMed ID: 14673600
    [Abstract] [Full Text] [Related]

  • 31. Somatic deletion of the NF1 gene in a neurofibromatosis type 1-associated malignant melanoma demonstrated by digital PCR.
    Rübben A, Bausch B, Nikkels A.
    Mol Cancer; 2006 Sep 10; 5():36. PubMed ID: 16961930
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Biallelic inactivation of TP53 rarely contributes to the development of malignant peripheral nerve sheath tumors.
    Lothe RA, Smith-Sørensen B, Hektoen M, Stenwig AE, Mandahl N, Saeter G, Mertens F.
    Genes Chromosomes Cancer; 2001 Feb 10; 30(2):202-6. PubMed ID: 11135438
    [Abstract] [Full Text] [Related]

  • 39. Losses in chromosomes 17, 19, and 22q in neurofibromatosis type 1 and sporadic neurofibromas: a comparative genomic hybridization analysis.
    Koga T, Iwasaki H, Ishiguro M, Matsuzaki A, Kikuchi M.
    Cancer Genet Cytogenet; 2002 Jul 15; 136(2):113-20. PubMed ID: 12237234
    [Abstract] [Full Text] [Related]

  • 40. Two sporadic spinal neurofibromatosis patients with malignant peripheral nerve sheath tumour.
    Fauth C, Kehrer-Sawatzki H, Zatkova A, Machherndl-Spandl S, Messiaen L, Amann G, Hainfellner JA, Wimmer K.
    Eur J Med Genet; 2009 Jul 15; 52(6):409-14. PubMed ID: 19665063
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 60.